Professor Stephen Riordan
Gastroenterology and the Liver
MBBS (Hons), MD (UNSW), FRACP, FRCP (London)
Scientific Publications
33. |
Luminal anti-gliadin antibodies in small intestinal bacterial overgrowth. American Journal of Gastroenterology 1997; 92: 1335-1338. |
34. |
Treatment of hepatic encephalopathy. New England Journal of Medicine 1997; 337: 473-479. |
35. |
Bioartificial liver support: developments in hepatocyte culture and bioreactor design. British Medical Bulletin 1997; 53: 1-15. |
36. |
Experience in design of controlled clinical trials in acute liver failure. In: Crepaldi G, Demetriou AA, Muraca M (Eds). Bioartificial Liver Support Systems: The Critical Issues. CIC Edizioni Internationali, Rome, 1997: 104-115. |
37. |
The prevalence of liver damage in human small intestinal bacterial overgrowth. Journal of Hepatology 1997; 26 (Suppl 1): 177. |
38. |
Hepatitis C virus-specific T helper cell responses in recurrent hepatitis C after liver transplantation. Journal of Hepatology 1997; 26 (Suppl 1): 145. |
39. |
Hepatotoxicity of designer drugs. Proceedings of the Royal College of Pathologists Scientific Conference, London, 1998. |
40. |
Liver disease due to illicit substance use. Addiction Biology 1998; 3: 47-53. |
41. |
Liver damage in human small intestinal bacterial overgrowth. American Journal of Gastroenterology 1998; 93: 234-237. |
42. |
Preoperative investigation and indication for operation in hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Surgery 1998; 5: 1-6. |
43. |
Interleukin-6 and small intestinal luminal immunoglobulins. Digestive Diseases and Sciences 1998; 43: 442-445. |
44. |
A randomised study comparing ribavirin and interferon-alpha monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998; 27: 1403-1407. |
45. |
Evolving therapies for chronic viral hepatitis. Gastroenterology Today 1998; 2: 29-35. |
46. |
Metabolic activity and clinical efficacy of animal and human hepatocytes in bioartificial support systems for acute liver failure. International Journal of Artificial Organs 1998; 21: 312-318. |
47. |
Tumour ablation and hepatic decompensation rates with multi-agent chemoembolisation of hepatocellular carcinoma. Quarterly Journal of Medicine 1998; 91: 821-828. |
48. |
The bioartificial liver. In: Advances in Therapeutic Hepatology - A World View. International Association for the Study of the Liver Postgraduate Syllabus, Chicago, 1998: 155-163. |